These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

804 related items for PubMed ID: 11229477

  • 1. Increased production of intracellular interleukin-1 receptor antagonist type I in the synovium of mice with collagen-induced arthritis: a possible role in the resolution of arthritis.
    Gabay C, Marinova-Mutafchieva L, Williams RO, Gigley JP, Butler DM, Feldmann M, Arend WP.
    Arthritis Rheum; 2001 Feb; 44(2):451-62. PubMed ID: 11229477
    [Abstract] [Full Text] [Related]

  • 2. Production of intracellular IL-1alpha, IL-1beta, and IL-1Ra isoforms by activated human dermal and synovial fibroblasts: phenotypic differences between human dermal and synovial fibroblasts.
    Maret M, Chicheportiche R, Dayer JM, Gabay C.
    Cytokine; 2004 Mar 07; 25(5):193-203. PubMed ID: 15036245
    [Abstract] [Full Text] [Related]

  • 3. Mice transgenic for intracellular interleukin-1 receptor antagonist type 1 are protected from collagen-induced arthritis.
    Palmer G, Talabot-Ayer D, Szalay-Quinodoz I, Maret M, Arend WP, Gabay C.
    Eur J Immunol; 2003 Feb 07; 33(2):434-40. PubMed ID: 12645941
    [Abstract] [Full Text] [Related]

  • 4. Articular inflammation is controlled by myeloid cell-derived interleukin 1 receptor antagonist during the acute phase of arthritis in mice.
    Lamacchia C, Rodriguez E, Palmer G, Vigne S, Martin P, Talabot-Ayer D, Seemayer CA, Gabay C.
    Ann Rheum Dis; 2012 Feb 07; 71(2):281-7. PubMed ID: 22072017
    [Abstract] [Full Text] [Related]

  • 5. Mouse IL-1 receptor antagonist isoforms: complementary DNA cloning and protein expression of intracellular isoform and tissue distribution of secreted and intracellular IL-1 receptor antagonist in vivo.
    Gabay C, Porter B, Fantuzzi G, Arend WP.
    J Immunol; 1997 Dec 15; 159(12):5905-13. PubMed ID: 9550387
    [Abstract] [Full Text] [Related]

  • 6. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA, Lubberts E, Helsen MM, Saxne T, Coenen-de Roo CJ, Heinegård D, van den Berg WB.
    Arthritis Res; 1999 Dec 15; 1(1):81-91. PubMed ID: 11056663
    [Abstract] [Full Text] [Related]

  • 7. Severity of murine collagen-induced arthritis correlates with increased CYP7B activity: enhancement of dehydroepiandrosterone metabolism by interleukin-1beta.
    Dulos J, Verbraak E, Bagchus WM, Boots AM, Kaptein A.
    Arthritis Rheum; 2004 Oct 15; 50(10):3346-53. PubMed ID: 15476247
    [Abstract] [Full Text] [Related]

  • 8. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: a comparative study using anti-TNFalpha, anti-IL-1alpha/beta and IL-1Ra.
    Joosten LA, Helsen MM, van de Loo FA, van den Berg WB.
    Arthritis Rheum; 2008 Feb 15; 58(2 Suppl):S110-22. PubMed ID: 18240201
    [Abstract] [Full Text] [Related]

  • 9. Enhancement of collagen-induced arthritis in mice genetically deficient in extracellular superoxide dismutase.
    Ross AD, Banda NK, Muggli M, Arend WP.
    Arthritis Rheum; 2004 Nov 15; 50(11):3702-11. PubMed ID: 15529385
    [Abstract] [Full Text] [Related]

  • 10. The differential production of three forms of IL-1 receptor antagonist by human neutrophils and monocytes.
    Malyak M, Smith MF, Abel AA, Hance KR, Arend WP.
    J Immunol; 1998 Aug 15; 161(4):2004-10. PubMed ID: 9712073
    [Abstract] [Full Text] [Related]

  • 11. Electrotransfer of human IL-1Ra into skeletal muscles reduces the incidence of murine collagen-induced arthritis.
    Jeong JG, Kim JM, Ho SH, Hahn W, Yu SS, Kim S.
    J Gene Med; 2004 Oct 15; 6(10):1125-33. PubMed ID: 15452879
    [Abstract] [Full Text] [Related]

  • 12. Action of intracellular IL-1Ra (Type 1) is independent of the IL-1 intracellular signalling pathway.
    Evans I, Dower SK, Francis SE, Crossman DC, Wilson HL.
    Cytokine; 2006 Mar 07; 33(5):274-80. PubMed ID: 16564702
    [Abstract] [Full Text] [Related]

  • 13. Protection against collagen-induced arthritis by intramuscular gene therapy with an expression plasmid for the interleukin-1 receptor antagonist.
    Kim JM, Jeong JG, Ho SH, Hahn W, Park EJ, Kim S, Yu SS, Lee YW, Kim S.
    Gene Ther; 2003 Sep 07; 10(18):1543-50. PubMed ID: 12907945
    [Abstract] [Full Text] [Related]

  • 14. Arthritis in mice that are deficient in interleukin-1 receptor antagonist is dependent on genetic background.
    Zhou F, He X, Iwakura Y, Horai R, Stuart JM.
    Arthritis Rheum; 2005 Dec 07; 52(12):3731-8. PubMed ID: 16320323
    [Abstract] [Full Text] [Related]

  • 15. Enhanced Th1 and Th17 responses and arthritis severity in mice with a deficiency of myeloid cell-specific interleukin-1 receptor antagonist.
    Lamacchia C, Palmer G, Seemayer CA, Talabot-Ayer D, Gabay C.
    Arthritis Rheum; 2010 Feb 07; 62(2):452-62. PubMed ID: 20112392
    [Abstract] [Full Text] [Related]

  • 16. Pre-interleukin-1alpha expression reduces cell growth and increases interleukin-6 production in SaOS-2 osteosarcoma cells: Differential inhibitory effect of interleukin-1 receptor antagonist (icIL-1Ra1).
    Palmer G, Trolliet S, Talabot-Ayer D, Mézin F, Magne D, Gabay C.
    Cytokine; 2005 Jul 21; 31(2):153-60. PubMed ID: 15923123
    [Abstract] [Full Text] [Related]

  • 17. Gamma/delta T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis.
    Ito Y, Usui T, Kobayashi S, Iguchi-Hashimoto M, Ito H, Yoshitomi H, Nakamura T, Shimizu M, Kawabata D, Yukawa N, Hashimoto M, Sakaguchi N, Sakaguchi S, Yoshifuji H, Nojima T, Ohmura K, Fujii T, Mimori T.
    Arthritis Rheum; 2009 Aug 21; 60(8):2294-303. PubMed ID: 19644886
    [Abstract] [Full Text] [Related]

  • 18. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
    Lubberts E, Koenders MI, Oppers-Walgreen B, van den Bersselaar L, Coenen-de Roo CJ, Joosten LA, van den Berg WB.
    Arthritis Rheum; 2004 Feb 21; 50(2):650-9. PubMed ID: 14872510
    [Abstract] [Full Text] [Related]

  • 19. Macrophage migration inhibitory factor up-regulates the expression of interleukin-8 messenger RNA in synovial fibroblasts of rheumatoid arthritis patients: common transcriptional regulatory mechanism between interleukin-8 and interleukin-1beta.
    Onodera S, Nishihira J, Koyama Y, Majima T, Aoki Y, Ichiyama H, Ishibashi T, Minami A.
    Arthritis Rheum; 2004 May 21; 50(5):1437-47. PubMed ID: 15146413
    [Abstract] [Full Text] [Related]

  • 20. Soluble interleukin-1 receptor accessory protein ameliorates collagen-induced arthritis by a different mode of action from that of interleukin-1 receptor antagonist.
    Smeets RL, Joosten LA, Arntz OJ, Bennink MB, Takahashi N, Carlsen H, Martin MU, van den Berg WB, van de Loo FA.
    Arthritis Rheum; 2005 Jul 21; 52(7):2202-11. PubMed ID: 15986350
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.